A 36-year-old client who has a diagnosis of fibrocystic breast changes calls the nurse in the clinic reporting symptoms. Which information is likely to change the treatment plan?
Explanation & Rationale
A. The lumps are smaller and less painful after starting oral contraceptives: This finding indicates a positive response to hormonal therapy. Oral contraceptives can regulate hormonal fluctuations, reducing fibrocystic breast changes, and typically does not require altering the treatment plan. B. Firm and movable lumps are in the upper outer breast quadrants: Fibrocystic breast changes commonly present as multiple, bilateral, firm, and movable lumps, often in the upper outer quadrants. This is consistent with the diagnosis and expected findings, so the current treatment plan would not be changed. C. An area on the breast is hot, pink, and tender to the touch: Localized erythema, warmth, and tenderness suggest acute inflammation or possible infection (mastitis or abscess) rather than typical fibrocystic changes. This finding requires immediate reassessment, potential antibiotic therapy, or additional diagnostic evaluation, indicating a likely change in the treatment plan. D. The lumps get more painful before the client's menstrual period: Cyclical premenstrual breast tenderness is characteristic of fibrocystic changes. This pattern is expected and does not necessitate altering the current management approach.